Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 06, 2023

BUY
$3.41 - $12.93 $671 - $2,547
197 Added 143.8%
334 $2,000
Q3 2022

Oct 07, 2022

BUY
$12.59 - $17.67 $1,724 - $2,420
137 New
137 $2,000
Q1 2022

Apr 08, 2022

SELL
$13.81 - $18.6 $469 - $632
-34 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$17.26 - $22.02 $586 - $748
34 New
34 $1,000

Others Institutions Holding NGM

About NGM BIOPHARMACEUTICALS INC


  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.